FMP
Pherecydes Pharma Société anonyme
ALPHE.PA
EURONEXT
Inactive Equity
Pherecydes Pharma SA develops antibacterial treatments based on the use of bacteriophage viruses or phages. It develops a portfolio of therapeutics, such as anti-Staphylococcus aureusphages for the treatment of bone/joint and diabetic foot ulcer infections; anti-Pseudomonas aeruginosa phages for the treatment of complicated urinary tract infections; and anti-Escherichia coli phages for the treatment of respiratory tract infections. The company was founded in 2006 and is based in Romainville, France.
2 EUR
-0.01 (-0.5%)
About
ceo
Mr. Thibaut du Fayet
sector
Healthcare
industry
Biotechnology
website
https://www.pherecydes-pharma.com
exchange
EURONEXT
Description
Pherecydes Pharma SA develops antibacterial treatments based on the use of bacteriophage viruses or phages. It develops a portfolio of therapeutics, such as anti-Staphylococcus aureusphages for the treatment of bone/joint and diabetic foot ulcer infections; anti-Pseudomonas aeruginosa phages for the treatment of complicated urinary tract infections; and anti-Escherichia coli phages for the treatment of respiratory tract infections. The company was founded in 2006 and is based in Romainville, France.
CIK
N/A
ISIN
N/A
CUSIP
N/A
Address
102 avenue Gaston Roussel
Phone
33 1 48 40 65 35
Country
FR
Employee
29
IPO Date
Feb 5, 2021
Summary
CIK
-
Exchange
EURONEXT
Industry
Biotechnology
Sector
Healthcare
CUSIP
-
ISIN
-
Country
FR
Price
2
Beta
0.99
Volume Avg.
10.51k
Market Cap
15.83M
Shares
-
52-Week
1.715-4.45
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-2.67
P/B
-
Website
https://www.pherecydes-pharma.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest ALPHE.PA News
It looks like there's no news available.
